Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 762,109 |
|
|||||
| News | - | ||||||
| Day High | 12.65 | Low High |
|||||
| Day Low | 12.01 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| NovoCure Ltd | NVCR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.32 | 2.62% | 12.55 | 18:46:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.15 | 12.01 | 12.65 | 12.635 | 12.23 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,518 | 762,109 | US$ 12.45 | US$ 9,486,763 | - | 10.87 - 83.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:50:08 | 2 | US$ 12.50 | USD |
NovoCure Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.35B | 107.09M | - | 509.34M | -207.04M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NovoCure News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVCR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.89 | 12.65 | 11.70 | 12.14 | 993,266 | 0.66 | 5.55% |
| 1 Month | 15.63 | 15.63 | 11.70 | 13.42 | 1,140,066 | -3.08 | -19.71% |
| 3 Months | 14.35 | 18.04 | 11.70 | 14.56 | 1,299,144 | -1.80 | -12.54% |
| 6 Months | 14.48 | 18.04 | 10.87 | 13.88 | 1,366,723 | -1.93 | -13.33% |
| 1 Year | 61.12 | 83.60 | 10.87 | 25.01 | 1,519,459 | -48.57 | -79.47% |
| 3 Years | 208.82 | 232.76 | 10.87 | 60.70 | 944,549 | -196.27 | -93.99% |
| 5 Years | 45.12 | 232.76 | 10.87 | 76.38 | 934,515 | -32.57 | -72.19% |
NovoCure Description
| NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. |
